DK1143994T3 - Anvendelse af apoptosis-fremkaldende midler ved fremstilling af et medikament til behandling af (auto)immunitetssygdomme - Google Patents
Anvendelse af apoptosis-fremkaldende midler ved fremstilling af et medikament til behandling af (auto)immunitetssygdommeInfo
- Publication number
- DK1143994T3 DK1143994T3 DK00900970T DK00900970T DK1143994T3 DK 1143994 T3 DK1143994 T3 DK 1143994T3 DK 00900970 T DK00900970 T DK 00900970T DK 00900970 T DK00900970 T DK 00900970T DK 1143994 T3 DK1143994 T3 DK 1143994T3
- Authority
- DK
- Denmark
- Prior art keywords
- auto
- apoptosis
- medicament
- manufacture
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99200056 | 1999-01-11 | ||
PCT/NL2000/000013 WO2000041497A2 (en) | 1999-01-11 | 2000-01-10 | Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1143994T3 true DK1143994T3 (da) | 2003-10-20 |
Family
ID=8239795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00900970T DK1143994T3 (da) | 1999-01-11 | 2000-01-10 | Anvendelse af apoptosis-fremkaldende midler ved fremstilling af et medikament til behandling af (auto)immunitetssygdomme |
Country Status (18)
Country | Link |
---|---|
US (1) | US20050271624A1 (ja) |
EP (1) | EP1143994B1 (ja) |
JP (1) | JP2003500336A (ja) |
AT (1) | ATE244014T1 (ja) |
AU (1) | AU3083500A (ja) |
CA (1) | CA2359392A1 (ja) |
DE (1) | DE60003632T2 (ja) |
DK (1) | DK1143994T3 (ja) |
EA (1) | EA200100770A1 (ja) |
ES (1) | ES2202039T3 (ja) |
HU (1) | HUP0200552A2 (ja) |
IL (2) | IL144228A0 (ja) |
MX (1) | MXPA01006998A (ja) |
NO (1) | NO20013397L (ja) |
PT (1) | PT1143994E (ja) |
TR (1) | TR200102713T2 (ja) |
WO (1) | WO2000041497A2 (ja) |
ZA (1) | ZA200105632B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2321485T3 (es) * | 2001-03-30 | 2009-06-08 | Leadd B.V. | Proteinas de fusion para tratamiento especifico de cancer y de enfermedades autoinmunes. |
CN1582301A (zh) * | 2001-05-25 | 2005-02-16 | 尼莫克斯股份有限公司 | 有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽 |
MXPA04000561A (es) * | 2001-07-19 | 2005-02-17 | Nymox Corp | Peptidos eficaces en el tratamiento de tumores y otras condiciones que requieren la remocion o destruccion de celulas. |
US7317077B2 (en) * | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5670488A (en) * | 1992-12-03 | 1997-09-23 | Genzyme Corporation | Adenovirus vector for gene therapy |
US5981502A (en) * | 1990-09-12 | 1999-11-09 | Leadd B.V. | Methods and compositions for inducing apoptosis in tumor cells |
EP0878546A1 (en) * | 1997-04-15 | 1998-11-18 | Leadd B.V. | A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin |
US5792751A (en) * | 1992-04-13 | 1998-08-11 | Baylor College Of Medicine | Tranformation of cells associated with fluid spaces |
NZ309171A (en) * | 1995-06-07 | 2000-04-28 | Leadd Bv | use of apoptin as an antitumour agent which specifically kills tumour and not normal cells |
DE19704979A1 (de) * | 1996-02-07 | 1997-08-14 | Max Delbrueck Centrum | Retroviraler Vektor für den Gentransfer eines IL6-Antagonisten in humane hämatopoetische Stammzellen |
TR199902068T2 (xx) * | 1997-02-28 | 1999-12-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | �ltihap h�crelerinin gen tedavisi ile kendi kendini d�zenleyen apoptozu. |
JPH10324699A (ja) * | 1997-03-21 | 1998-12-08 | Sankyo Co Ltd | 抗ヒトFasヒト化抗体 |
ZA982371B (en) * | 1997-03-21 | 1998-09-28 | Sankyo Co | Humanized anti-human fas antibody |
-
2000
- 2000-01-10 DE DE60003632T patent/DE60003632T2/de not_active Expired - Fee Related
- 2000-01-10 DK DK00900970T patent/DK1143994T3/da active
- 2000-01-10 AT AT00900970T patent/ATE244014T1/de not_active IP Right Cessation
- 2000-01-10 AU AU30835/00A patent/AU3083500A/en not_active Abandoned
- 2000-01-10 WO PCT/NL2000/000013 patent/WO2000041497A2/en active IP Right Grant
- 2000-01-10 PT PT00900970T patent/PT1143994E/pt unknown
- 2000-01-10 CA CA002359392A patent/CA2359392A1/en not_active Abandoned
- 2000-01-10 EA EA200100770A patent/EA200100770A1/ru unknown
- 2000-01-10 ES ES00900970T patent/ES2202039T3/es not_active Expired - Lifetime
- 2000-01-10 IL IL14422800A patent/IL144228A0/xx unknown
- 2000-01-10 MX MXPA01006998A patent/MXPA01006998A/es unknown
- 2000-01-10 HU HU0200552A patent/HUP0200552A2/hu unknown
- 2000-01-10 EP EP20000900970 patent/EP1143994B1/en not_active Expired - Lifetime
- 2000-01-10 JP JP2000593120A patent/JP2003500336A/ja active Pending
- 2000-01-10 TR TR2001/02713T patent/TR200102713T2/xx unknown
-
2001
- 2001-07-09 ZA ZA200105632A patent/ZA200105632B/en unknown
- 2001-07-09 NO NO20013397A patent/NO20013397L/no not_active Application Discontinuation
- 2001-07-10 IL IL144228A patent/IL144228A/en not_active IP Right Cessation
-
2005
- 2005-02-25 US US11/067,001 patent/US20050271624A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2359392A1 (en) | 2000-07-20 |
AU3083500A (en) | 2000-08-01 |
EA200100770A1 (ru) | 2002-02-28 |
PT1143994E (pt) | 2003-11-28 |
JP2003500336A (ja) | 2003-01-07 |
NO20013397L (no) | 2001-09-11 |
ATE244014T1 (de) | 2003-07-15 |
TR200102713T2 (tr) | 2002-05-21 |
WO2000041497A3 (en) | 2000-09-28 |
IL144228A (en) | 2009-06-15 |
EP1143994B1 (en) | 2003-07-02 |
NO20013397D0 (no) | 2001-07-09 |
ES2202039T3 (es) | 2004-04-01 |
EP1143994A2 (en) | 2001-10-17 |
IL144228A0 (en) | 2002-05-23 |
HUP0200552A2 (en) | 2002-06-29 |
DE60003632T2 (de) | 2004-04-15 |
WO2000041497A2 (en) | 2000-07-20 |
MXPA01006998A (es) | 2002-05-06 |
US20050271624A1 (en) | 2005-12-08 |
ZA200105632B (en) | 2002-10-09 |
DE60003632D1 (de) | 2003-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN08064A1 (en) | Albumin fusion proteins | |
WO2005077042A3 (en) | Albumin fusion proteins | |
MX2009002816A (es) | Proteinas de fusion de albumina. | |
FI963101A (fi) | Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut | |
WO2003060071A3 (en) | Albumin fusion proteins | |
WO2001079442A3 (en) | Albumin fusion proteins | |
EP1385545A4 (en) | HUMANIZED ANTIBODIES | |
WO2003048327A3 (en) | Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection | |
CY1108489T1 (el) | Παραγωγη τετρασθενων αντισωματων | |
HUP0300369A2 (hu) | Többértékű antitestek és alkalmazásuk | |
NO20000450L (no) | Substituerte fenylalaninforbindelser som inhiberer leukocytt- adhesjon mediert av VLA-4 | |
EP4218815A3 (en) | Use of anti il-1beta antibodies | |
WO2001064889A3 (en) | Tnf-alpha variants for the treatment of tnf-alpha related disorders | |
MX2009012948A (es) | Nuevas indicaciones para la terapia anti-il-1-beta. | |
DK1143994T3 (da) | Anvendelse af apoptosis-fremkaldende midler ved fremstilling af et medikament til behandling af (auto)immunitetssygdomme | |
NO20076663L (no) | Immunoglobuliner | |
WO2004099388A3 (en) | Cbl-b polypeptides, complexes and related methods | |
EP1475441A3 (fr) | Acides nucléiques et polypeptides spécifiques des souches pathogènes du genre Neisseria | |
DE60038955D1 (de) | AN DER OBERFLÄCHE VON KARZINOMZELLEN LOKALISIERTES COLLIGIN/HsP47 | |
DK1196188T3 (da) | VGF-selektive monoklonale antistoffer og deres anvendelse til behandling af VGF-relaterede lidelser | |
DK1377667T3 (da) | Fusionsproteiner til specifik behandling af cancer og autoimmunsygdomme | |
WO2005023979A3 (en) | Isolated s. mansoni nucleic acid molecules and uses thereof | |
WO2006048657A3 (en) | Fras related protein | |
WO2002063013A3 (en) | Human acid phosphatase gene | |
WO2001030366A3 (de) | Verwendung von parvoviren zur verbesserung des allgemeinzustandes bei tumorpatienten oder patienten mit chronischen oder konsumierenden erkrankungen |